Stay updated with breaking news from R Pac Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Data shows that the Trans-Arterial Micro-Perfusion platform increases intra-arterial pressure, improving drug delivery with 100-fold increase local tissue concentration of the therapy TAMP offers...
RenovoRx, Inc. , a clinical-stage biopharmaceutical company developing novel precision oncology therapies based on a local drug-delivery platform, today announced that Shaun R. Bagai, Chief...
RenovoRx, Inc. , a clinical-stage biopharmaceutical company developing novel precision oncology therapies based on a local drug-delivery platform, today announced that, in light of its recent...
LOS ALTOS - RenovoRx, Inc. , a clinical-stage biopharmaceutical company developing novel precision oncology therapies based on a local drug-delivery platform, today announced that Shaun Bagai,...
Cash position now expected to fund current operating plan into 2026 Financing provides cash runway to advance the ongoing pivotal Phase III TIGeR-PaC trial through the second interim readout and...